Serum S100B in manic bipolar disorder patients: Systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Affective Disorders

• Publication date

  2016-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jad.2016.07.030PMID 27475892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B

  2014cited by this paper
• Serum S100B Represents a New Biomarker for Mood Disorders

  2013cited by this paper
• Reduced Serum Levels of Neuron Specific Enolase (NSE) in Drug-Naïve Subjects with Major Depression and Bipolar Disorder

  2013cited by this paper
• Functions of S100 proteins.

  2012cited by this paper
• Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies.

  2011cited by this paper
• Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies

  2010cited by this paper
• S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research.

  2010cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Use of wireless telephones and serum S100B levels: a descriptive cross-sectional study among healthy Swedish adults aged 18-65 years.

  2009cited by this paper
• Serum levels of S100B are decreased in chronic starvation and normalize with weight gain

  2008cited by this paper
• The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression

  2008cited by this paper
• Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.

  2007cited by this paper
• Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.

  2007cited by this paper
• Serum S100B and antioxidant enzymes in bipolar patients.

  2007cited by this paper
• Gliogenesis and glial pathology in depression.

  2007cited by this paper
• Regionally Specific Changes in Levels of Cortical S100β in Bipolar 1 Disorder but not Schizophrenia

  2006cited by this paper
• Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder.

  2004cited by this paper
• [Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia].

  2004cited by this paper
• Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

  2004cited by this paper
• The Janus face of glial-derived S100B: Beneficial and detrimental functions in the brain

  2003cited by this paper
• Reduced left hemispheric white matter volume in twins with bipolar I disorder.

  2003cited by this paper
• Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study.

  2002cited by this paper
• S100B is increased in mood disorders and may be reduced by antidepressive treatment

  2002cited by this paper
• Astrocytes induce manganese superoxide dismutase in brain capillary endothelial cells

  2001cited by this paper
• Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder

  2000cited by this paper
• The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

  1998cited by this paper
• MRI subcortical signal hyperintensities in mania at first hospitalization.

  1993cited by this paper
• The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

  1992cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• A Rating Scale for Mania: Reliability, Validity and Sensitivity

  1978cited by this paper

• The role of blood–brain barrier dysfunction in cognitive impairments in bipolar disorder—a narrative review

  2025cites this paper
• Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.

  2025cites this paper
• Across Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders

  2025cites this paper
• Neurogliovascular alterations in brain pathologies across lifespan

  2024cites this paper
• Glymphatic System and Psychiatric Disorders: A Rapid Comprehensive Scoping Review

  2024cites this paper
• Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review

  2023cites this paper
• Circulating S100B levels at birth and risk of six major neuropsychiatric or neurological disorders: a two-sample Mendelian Randomization Study

  2023cites this paper
• Transcriptional changes in the rat brain induced by repetitive transcranial magnetic stimulation

  2023cites this paper
• Epigenetic Alterations of Brain Non-Neuronal Cells in Major Mental Diseases

  2023cites this paper
• Composite immune marker scores associated with severe mental disorders and illness course

  2022cites this paper
• Role of Klotho Protein in Neuropsychiatric Disorders: A Narrative Review

  2022cites this paper
• Glymphatic System Dysfunction in Central Nervous System Diseases and Mood Disorders

  2022cites this paper
• ProBDNF as an Indicator of Improvement among Women with Depressive Episodes

  2022cites this paper
• Neurons | Calcium Signaling in Neurons and Oocytes

  2021cites this paper
• Bipolar disorder as a gliopathy

  2021cites this paper
• Role of Astrocytes in Major Neuropsychiatric Disorders

  2021cites this paper
• Prenatal diagnosis and molecular cytogenetic characterization of a pure ring chromosome 21 with a 4.657-Mb 21q22.3 deletion.

  2021cites this paper
• Glymphatic Dysfunction: A Bridge Between Sleep Disturbance and Mood Disorders

  2021cites this paper
• Growing role of S100B protein as a putative therapeutic target for neurological -and nonneurological- disorders.

  2021cites this paper
• Correlation between S100B and severity of depression in MDD: A meta-analysis

  2021cites this paper
• Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.

  2021cites this paper
• Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels.

  2020cites this paper
• Systematic comparative analysis of Mendelian randomization methods for inferring causal genes of complex phenotypes and the application to psychiatric diseases

  2020cites this paper
• Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies

  2020cites this paper
• Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

  2020cites this paper
• S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders.

  2020cites this paper
• Reactivity of astrocytes in the periaqueductal gray matter of rats treated with monosodium glutamate.

  2020cites this paper
• Autism spectrum disorder, anxiety and severe depression in a male patient with deletion and duplication in the 21q22.3 region: A case report.

  2019cites this paper
• The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application

  2019cites this paper
• Autism spectrum disorder , anxiety and severe depression in a male patient with deletion and duplication in the 21 q 22 . 3 region : A case report

  2019cites this paper
• The S100B story: from biomarker to active factor in neural injury

  2018cites this paper
• Does S100B have a potential role in affective disorders? A literature review

  2018cites this paper
• Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder

  2017cites this paper
• R E S E A R C H A R T I C L E Biochanin A Has Protective and Therapeutic Effects against Li 2 CO 3 -induced Nephrotoxicity in Rats Model

  year unknowncites this paper